These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23150176)

  • 1. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
    Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
    Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
    Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
    Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
    Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
    Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
    Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
    Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
    Huang J; Yao X; Zhang J; Dong B; Chen Q; Xue W; Liu D; Huang Y
    Cancer Sci; 2013 Dec; 104(12):1609-17. PubMed ID: 24112779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2.
    Gao Y; Ma X; Yao Y; Li H; Fan Y; Zhang Y; Zhao C; Wang L; Ma M; Lei Z; Zhang X
    Oncotarget; 2016 Apr; 7(15):20324-37. PubMed ID: 26967247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
    Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
    J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
    Lin L; Cai J
    J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
    Song H; Rao Y; Zhang G; Kong X
    Oncol Res; 2018 Apr; 26(3):457-466. PubMed ID: 28877780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
    Zhang WB; Pan ZQ; Yang QS; Zheng XM
    Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.